{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "", "close" : "", "flags" : {"h" : "Thanksgiving Day"}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
prnewswire

DuPont CEO Outlines Plan for Delivering Growth in 2010 and Beyond

Reaffirms full-year 2009 Earnings Outlook of $1.95 to $2.05 Per Share

  • Press Release
  • Source: DuPont
  • On 3:30 pm EST, Thursday November 5, 2009

NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- At the Goldman Sachs Industrials Conference, DuPont CEO Ellen Kullman outlined how DuPont expects to build on its core competitive advantage of market-driven scientific innovation and its strong position in targeted global growth markets to deliver 20 percent compound annual earnings growth for the 2009-2012 period.

Related Quotes

SymbolPriceChange
DD35.15+0.48
Chart for DU PONT E I DE NEM
{"s" : "dd","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Kullman said the company is focused on delivering superior growth for shareholders through market-driven and science-based solutions, carefully prioritized investments and industry-leading productivity.

"We are focused on achieving higher revenue and earnings growth rate for our company, and delivering increased value to our shareholders," Kullman said. "By delivering on the commitments we made at the start of 2009, DuPont is meeting the economic recovery as a stronger, faster and more agile global competitor. We are well-positioned to outperform the rate at which markets recover and improve."

By executing on its priorities, DuPont expects to generate about 10 percent top-line compound annual growth for the 2009-2012 period, Kullman said. The company also plans to capture $1 billion in fixed cost productivity and $1 billion in working capital productivity gains during the 2010-2012 timeframe.

Kullman said DuPont expects to deliver, on average, 20 percent earnings per share growth, from 2009 estimated full-year earnings on a year-over-year basis through 2012. She said that DuPont expects to grow earnings in 2010 -- despite anticipated declines in pharmaceutical royalties after patents expire in 2010 -- to a range of $2.10 to $2.40 per share.

Kullman also reaffirmed the company's full-year 2009 earnings outlook of $1.95 to $2.05 per share, excluding significant items which are estimated to be $0.15 per share for full-year 2009 or $1.80 to $1.90 per share on a reported basis.*

DuPont (NYSE: DD - News) is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont's filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products. The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.

* Schedule B of the company's third quarter 2009 earnings news release contains a reconciliation of significant items.

Sponsored Links

Copyright © 2009 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.